Skin Health: Glutathione is often touted for its skin-brightening effects, making it a popular choice in cosmetic treatments
NAD+ therapy can support cellular energy and recovery during the off-cycle, complementing gains made during active peptide treatment
However, the National Institute for Health and Care Excellence (Nice) cannot begin assessing the drug for NHS rollout because Novo Nordisk, its manufacturer, has yet to submit the evidence needed for an appraisal
Subscribe biotechnology, chronic disease, CMS, Donald Trump, Drug prices, Medicaid, Medicare, Medicare negotiation, Obesity, Pharmaceuticals, Policy, STAT+ Daniel covers the intersection of the health industry and the federal government